<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00279812</url>
  </required_header>
  <id_info>
    <org_study_id>IFR02/2005</org_study_id>
    <secondary_id>FSA 51949F</secondary_id>
    <nct_id>NCT00279812</nct_id>
  </id_info>
  <brief_title>Selenium and Immune Function</brief_title>
  <official_title>Selenium and Immune Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Quadram Institute Bioscience</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Food Standards Agency, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Quadram Institute Bioscience</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the relationship between dose and form of selenium on
      immune function, and to identify functional markers of selenium status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the proposed consequences of marginal selenium status is impaired immune function.
      Establishing the potential role of selenium as an enhancer of immune response in vivo may
      provide evidence-base for public health policy, with important consequences for preventing
      influenza and similar diseases in the elderly.

      The project consists of a placebo controlled selenium supplementation study and a dietary
      intervention with un-enriched and selenium enriched onions. In a parallel group design,
      subjects will be given either one of three doses of Selenomethionine (50, 100 or 200µg
      selenium/day) or a placebo per day or selenium enriched or un-enriched onions (in the form of
      test meals) for 12 weeks. Changes in the expression of Se-responsive genes and proteins in
      blood will be measured and compared with changes in plasma Se concentration and selected
      selenoproteins. The relationship between dietary Se intake and systemic and mucosal immune
      responses to influenza vaccine will be examined. Changes in immune cell populations and the
      influence of Se on NK and CD8 cytotoxicity will be determined by flow cytometry.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cellular and Humoral Immune Response</measure>
    <time_frame>12 weeks</time_frame>
    <description>Total glutathione peroxidase 1 activity in platelets after supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Selenium Status</measure>
    <time_frame>10 weeks</time_frame>
    <description>Plasma selenium concentration after supplementation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selenoproteins and Se-biomarkers</measure>
    <time_frame>10 weeks</time_frame>
    <description>Plasma selenoprotein P after the supllementation</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">133</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>50ug selenium enriched yeast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50ug/d selenium enriched yeast (containing 60% selenomethionine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>100ug selenium enriched yeast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100ug/d selenium enriched yeast (containing 60% selenomethionine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>200ug selenium enriched yeast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200ug/d selenium enriched yeast (containing 60% selenomethionine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control onion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 meals/wk containing un-enriched onions equivalent to 4ug/d Se</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enriched onion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 meals/wk containing enriched onions equivalent to 50ug/d Se</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>50ug selenium enriched yeast</intervention_name>
    <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
    <arm_group_label>50ug selenium enriched yeast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>100ug selenium enriched yeast</intervention_name>
    <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
    <arm_group_label>100ug selenium enriched yeast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>200ug selenium enriched yeast</intervention_name>
    <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
    <arm_group_label>200ug selenium enriched yeast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control onion</intervention_name>
    <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
    <arm_group_label>Control onion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enriched onion</intervention_name>
    <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
    <arm_group_label>Enriched onion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo supplement for 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women, age 50-64

          -  Plasma selenium level &lt;1.2µmol/l (±10%)

        Exclusion Criteria:

          -  Elevated blood pressure measurements (&lt;90/50 or &lt;95/50 if symptomatic or &gt;160/100)

          -  Body mass index (BMI) &lt;18.5 or &gt;35

          -  Results of the clinical screening which are judged by the Human Nutrition Unit (HNU)
             Medical advisor to be indicative of a health problem and could compromise the
             well-being of the volunteer if they participated, or which would affect the data.

          -  Smokers

          -  Diagnosed with gastrointestinal disease (excluding hiatus hernia unless symptomatic or
             study intervention/procedure is contraindicated) for which they have been taking
             prescription drugs on a chronic basis.

          -  Diagnosed with a long-term illness requiring active treatment, e.g. diabetes, cancer,
             cardiovascular disease.

          -  On regularly prescribed medication known to have a profound effect on the immune
             function

          -  Regularly using antacids and laxatives (at least once a week)

          -  Sufferers of hay-fever taking regular steroid medication

          -  Unwillingness to discontinue dietary (other than vitamins and minerals) or herbal
             supplements less than one month prior to the start of the study and for the duration
             of the study

          -  Blood donation within 16 weeks of the first study sample and who intend to donate
             blood less than 16 weeks after the last study sample

          -  Antibiotic use within four weeks prior to starting the study

          -  Those who receive or plan to receive any other type of immunisation during the study
             period

          -  Those who have received an immunisation within 6 months of the start of the study

          -  Intention to go on holiday/trips for more than 2 weeks during the twelve week
             intervention

          -  Those planning a holiday/trip that requires immunisation during the twelve week
             intervention period

          -  Parallel participation in another research project which involves dietary intervention
             or sampling of biological fluids/materials

          -  Allergic to eggs or egg products

          -  Allergic to chicken protein

          -  Allergic to the antibiotic Gentamicin

          -  A history of Guillain-Barre syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan J Fairweather-Tait, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of East Anglia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Food Research</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>January 19, 2006</study_first_submitted>
  <study_first_submitted_qc>January 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2006</study_first_posted>
  <results_first_submitted>November 9, 2015</results_first_submitted>
  <results_first_submitted_qc>September 28, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 16, 2018</results_first_posted>
  <last_update_submitted>September 28, 2017</last_update_submitted>
  <last_update_submitted_qc>September 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immune response</keyword>
  <keyword>Selenomethionine</keyword>
  <keyword>Selenium enriched foods</keyword>
  <keyword>Selenium status</keyword>
  <keyword>Selenium biomarkers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment ran from May until the following February in 2005, 2006, and 2007. Study completed in June 2008. 272 volunteers completed a screening questionnaire,182 volunteers had blood samples screened, total of 133 were recruited and 119 completed the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo
Selenomethionine (supplement) and selenium enriched onions</description>
        </group>
        <group group_id="P2">
          <title>50ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="P3">
          <title>100ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="P4">
          <title>200ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="P5">
          <title>Control Onion</title>
          <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
        </group>
        <group group_id="P6">
          <title>Enriched Onion</title>
          <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="23"/>
                <participants group_id="P5" count="20"/>
                <participants group_id="P6" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="23"/>
                <participants group_id="P5" count="17"/>
                <participants group_id="P6" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo
Selenomethionine (supplement) and selenium enriched onions</description>
        </group>
        <group group_id="B2">
          <title>50ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="B3">
          <title>100ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="B4">
          <title>200ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="B5">
          <title>Control Onion</title>
          <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
        </group>
        <group group_id="B6">
          <title>Enriched Onion</title>
          <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="21"/>
            <count group_id="B4" value="23"/>
            <count group_id="B5" value="17"/>
            <count group_id="B6" value="18"/>
            <count group_id="B7" value="119"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="17"/>
                    <measurement group_id="B6" value="18"/>
                    <measurement group_id="B7" value="119"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.8" spread="3.9"/>
                    <measurement group_id="B2" value="56.5" spread="4.6"/>
                    <measurement group_id="B3" value="58.4" spread="3.9"/>
                    <measurement group_id="B4" value="56.1" spread="3.9"/>
                    <measurement group_id="B5" value="58.2" spread="5.1"/>
                    <measurement group_id="B6" value="57.7" spread="4.2"/>
                    <measurement group_id="B7" value="57.12" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="11"/>
                    <measurement group_id="B6" value="12"/>
                    <measurement group_id="B7" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="17"/>
                    <measurement group_id="B6" value="18"/>
                    <measurement group_id="B7" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" spread="2.7"/>
                    <measurement group_id="B2" value="26.1" spread="3"/>
                    <measurement group_id="B3" value="26.3" spread="3.9"/>
                    <measurement group_id="B4" value="25.9" spread="3.8"/>
                    <measurement group_id="B5" value="26.6" spread="4.1"/>
                    <measurement group_id="B6" value="26.1" spread="2.4"/>
                    <measurement group_id="B7" value="26" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cellular and Humoral Immune Response</title>
        <description>Total glutathione peroxidase 1 activity in platelets after supplementation</description>
        <time_frame>12 weeks</time_frame>
        <population>Data from 117 subjects because of incomplete time-course experiment for one subject and baseline plasma selenium concentration for one subject</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo
Selenomethionine (supplement) and selenium enriched onions</description>
          </group>
          <group group_id="O2">
            <title>50ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>100ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>200ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Control Onion</title>
            <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>Enriched Onion</title>
            <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Cellular and Humoral Immune Response</title>
          <description>Total glutathione peroxidase 1 activity in platelets after supplementation</description>
          <population>Data from 117 subjects because of incomplete time-course experiment for one subject and baseline plasma selenium concentration for one subject</population>
          <units>umol/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="17"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.07"/>
                    <measurement group_id="O2" value="0.34" spread="0.16"/>
                    <measurement group_id="O3" value="0.34" spread="0.15"/>
                    <measurement group_id="O4" value="0.29" spread="0.09"/>
                    <measurement group_id="O5" value="0.35" spread="0.15"/>
                    <measurement group_id="O6" value="0.35" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Selenium Status</title>
        <description>Plasma selenium concentration after supplementation</description>
        <time_frame>10 weeks</time_frame>
        <population>Data from 117 subjects because of incomplete time-course experiment for one subject and baseline plasma selenium concentration for one subject</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo
Selenomethionine (supplement) and selenium enriched onions</description>
          </group>
          <group group_id="O2">
            <title>50ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>100ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>200ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Control Onion</title>
            <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>Enriched Onion</title>
            <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Selenium Status</title>
          <description>Plasma selenium concentration after supplementation</description>
          <population>Data from 117 subjects because of incomplete time-course experiment for one subject and baseline plasma selenium concentration for one subject</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="17"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.7" spread="16.5"/>
                    <measurement group_id="O2" value="118.3" spread="13.1"/>
                    <measurement group_id="O3" value="152.0" spread="24.3"/>
                    <measurement group_id="O4" value="177.4" spread="26.3"/>
                    <measurement group_id="O5" value="94.2" spread="15.0"/>
                    <measurement group_id="O6" value="106.0" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Selenoproteins and Se-biomarkers</title>
        <description>Plasma selenoprotein P after the supllementation</description>
        <time_frame>10 weeks</time_frame>
        <population>Data from 117 subjects because of incomplete time-course experiment for one subject and baseline plasma selenium concentration for one subject</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo
Selenomethionine (supplement) and selenium enriched onions</description>
          </group>
          <group group_id="O2">
            <title>50ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>100ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>200ug Selenium Enriched Yeast</title>
            <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Control Onion</title>
            <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>Enriched Onion</title>
            <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Selenoproteins and Se-biomarkers</title>
          <description>Plasma selenoprotein P after the supllementation</description>
          <population>Data from 117 subjects because of incomplete time-course experiment for one subject and baseline plasma selenium concentration for one subject</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="17"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.96" spread="0.86"/>
                    <measurement group_id="O2" value="6.17" spread="0.85"/>
                    <measurement group_id="O3" value="6.73" spread="1.01"/>
                    <measurement group_id="O4" value="6.59" spread="0.64"/>
                    <measurement group_id="O5" value="4.80" spread="1.03"/>
                    <measurement group_id="O6" value="5.72" spread="0.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo
Selenomethionine (supplement) and selenium enriched onions</description>
        </group>
        <group group_id="E2">
          <title>50ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (50ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="E3">
          <title>100ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (100ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="E4">
          <title>200ug Selenium Enriched Yeast</title>
          <description>Selenomethionine supplement (200ug/d Se) for 12 weeks</description>
        </group>
        <group group_id="E5">
          <title>Control Onion</title>
          <description>3 meals per week containing un-enriched onion (4ug/d) for 12 weeks</description>
        </group>
        <group group_id="E6">
          <title>Enriched Onion</title>
          <description>3 meals per week containing un-enriched onion (50ug/d) for 12 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>cold symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Charlotte Armah</name_or_title>
      <organization>Institute of Food Research</organization>
      <phone>01603 255 000 ext 5360</phone>
      <email>charlotte.armah@ifr.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

